How Important Are Emerging Markets To Abbott?

+11.68%
Upside
114
Market
127
Trefis
ABT: Abbott Laboratories logo
ABT
Abbott Laboratories

Abbott derives approximately 50% of its sales from emerging markets. This is one key reason as to why Abbott’s sales are largely affected due to foreign currency fluctuations. The company’s sales declined by 8.3% or $1680 million in 2015 due to foreign currency losses.

ABT_Q&A_Emerging_Markets

Further, the company’s established pharmaceutical division operates only in emerging markets. In February 2015, Abbott completed the sale of its developed markets business to Mylan N.V. However, Abbott retained its branded generics pharmaceutical business and products of its Established pharmaceutical Products segment in emerging markets.

ABT_Q&A_Emerging_Markets_1

Notes:

1) If you like or have any questions about our analysis, please write us back at content@trefis.com. We hope such lean communication sparks thinking, and encourages you to ask questions. The purpose of these analyses is to help you focus only on a few important things. 
2) Figures mentioned are approximate values to help our readers remember the key concepts more intuitively. For precise figures, please refer to our complete analysis for Abbott Laboratories
Relevant Articles
  1. What’s Next For Abbott Stock After A 6% Rise This Year?
  2. Is Abbott Stock Undervalued At $95?
  3. Which Is A Better Pick – Abbott Stock Or Amgen?
  4. Is Abbott Stock A Better Healthcare Pick Over Thermo Fisher Scientific?
  5. Lower Testing Demand To Weigh On Abbott’s Q2?
  6. Will Abbott Stock Rebound To Its 2022 Highs?

See More at Trefis | View Interactive Institutional Research (Powered by Trefis)

Get Trefis Technology